Inari Medical Statistics
Total Valuation
Inari Medical has a market cap or net worth of $2.67 billion. The enterprise value is $2.60 billion.
| Market Cap | 2.67B |
| Enterprise Value | 2.60B |
Important Dates
The last earnings date was Tuesday, April 30, 2024, after market close.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Inari Medical has 58.14 million shares outstanding. The number of shares has increased by 5.81% in one year.
| Shares Outstanding | 58.14M |
| Shares Change (YoY) | +5.81% |
| Shares Change (QoQ) | +12.29% |
| Owned by Insiders (%) | 9.51% |
| Owned by Institutions (%) | 102.29% |
| Float | 49.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.12 |
| Forward PS | 4.27 |
| PB Ratio | 5.96 |
| P/FCF Ratio | 144.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1,321.07, with an EV/FCF ratio of 140.28.
| EV / Earnings | n/a |
| EV / Sales | 4.99 |
| EV / EBITDA | 1,321.07 |
| EV / EBIT | n/a |
| EV / FCF | 140.28 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.71 |
| Quick Ratio | 2.10 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 16.03 |
| Debt / FCF | 1.70 |
| Interest Coverage | -44.50 |
Financial Efficiency
Return on equity (ROE) is -5.20% and return on invested capital (ROIC) is -4.09%.
| Return on Equity (ROE) | -5.20% |
| Return on Assets (ROA) | -3.90% |
| Return on Capital (ROIC) | -4.09% |
| Revenue Per Employee | $400,507 |
| Profits Per Employee | -$18,169 |
| Employee Count | 1,300 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, Inari Medical has paid $12.97 million in taxes.
| Income Tax | 12.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.64% in the last 52 weeks. The beta is 0.93, so Inari Medical's price volatility has been similar to the market average.
| Beta (1Y) | 0.93 |
| 52-Week Price Change | -33.64% |
| 50-Day Moving Average | 42.32 |
| 200-Day Moving Average | 56.09 |
| Relative Strength Index (RSI) | 62.06 |
| Average Volume (30 Days) | 1,427,824 |
Short Selling Information
The latest short interest is 4.41 million, so 7.59% of the outstanding shares have been sold short.
| Short Interest | 4.41M |
| Short Previous Month | 3.96M |
| Short % of Shares Out | 7.59% |
| Short % of Float | 8.89% |
| Short Ratio (days to cover) | 3.96 |
Income Statement
In the last 12 months, Inari Medical had revenue of $520.66 million and -$23.62 million in losses. Loss per share was -$0.41.
| Revenue | 520.66M |
| Gross Profit | 456.44M |
| Operating Income | -19.57M |
| Pretax Income | -10.65M |
| Net Income | -23.62M |
| EBITDA | 1.97M |
| EBIT | -10.41M |
| Loss Per Share | -$0.41 |
Balance Sheet
The company has $101.80 million in cash and $31.49 million in debt, giving a net cash position of $70.31 million or $1.21 per share.
| Cash & Cash Equivalents | 101.80M |
| Total Debt | 31.49M |
| Net Cash | 70.31M |
| Net Cash Per Share | $1.21 |
| Equity / Book Value | 447.23M |
| Book Value Per Share | 7.69 |
| Working Capital | 147.28M |
Cash Flow
In the last 12 months, operating cash flow was $25.65 million and capital expenditures -$7.15 million, giving a free cash flow of $18.51 million.
| Operating Cash Flow | 25.65M |
| Capital Expenditures | -7.15M |
| Free Cash Flow | 18.51M |
| FCF Per Share | $0.32 |
Margins
Gross margin is 87.67%, with operating and profit margins of -3.76% and -4.54%.
| Gross Margin | 87.67% |
| Operating Margin | -3.76% |
| Pretax Margin | -2.04% |
| Profit Margin | -4.54% |
| EBITDA Margin | 0.38% |
| EBIT Margin | -2.00% |
| FCF Margin | 3.55% |
Dividends & Yields
Inari Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.81% |
| Shareholder Yield | -5.81% |
| Earnings Yield | -0.89% |
| FCF Yield | 0.69% |
Analyst Forecast
The average price target for Inari Medical is $65.71, which is 43.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $65.71 |
| Price Target Difference | 43.63% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 19.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Inari Medical has an Altman Z-Score of 8.3 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.3 |
| Piotroski F-Score | 4 |